Focus Carefully read the fine print about direct-to-consumer genetic tests

[McFurd]

San Diego Union Tribune - 4/9/2017 - Paul Sisson - Medical experts in San Diego said the federal government’s blessing of the nation’s first direct-to-consumer genetic testing service is sure to get aspiring competitors drooling — and that it’s not necessarily a good thing. “I think other companies have had a sort of wait-and-see attitude since the FDA took action with 23andMe back in 2013,” said Joe Panetta, chief executive of Biocom, the San Diego-based trade group that represents Southern California’s biotechnology industry. He was referring to regulators suspending 23andMe’s original genetic testing service in that year due to lack of substantiation for its marketing claims. Read more @ http://www.sandiegouniontribune.com/new ... story.html